ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma

Joshua Richter, MD, discusses long-term follow up data findings for multiple myeloma and their implications on front-line therapy options for patients.

An expert in the management of multiple myeloma discusses new data released from the GRIFFIN trial as well as real-world evidence regarding frontline autologous stem cell transplantation.

Joshua Richter, MD, provides an overview of new data from various trials presented at ASH 2020 regarding newly diagnosed patients with multiple myeloma.

An expert looks to the future directions in multiple myeloma and discusses upcoming advances in the field.